Intercept Pharmaceuticals, Inc. (ICPT) Social Stream
INTERCEPT PHARMACEUTICALS INC (ICPT) Price Targets From Analysts
Use the tables below to see what analysts covering INTERCEPT PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 12 | $82 | $18 | $32.538 | $13.69 | 137.68% |
| 2021-11-12 | 11 | $82 | $18 | $32.692 | $13.69 | 138.8% |
| 2021-12-09 | 11 | $82 | $18 | $32.153 | $13.69 | 134.86% |
| 2021-12-22 | 11 | $82 | $16 | $31.923 | $13.69 | 133.18% |
| 2022-01-11 | 11 | $82 | $16 | $32.307 | $13.69 | 135.99% |
| 2022-03-04 | 11 | $82 | $16 | $29.818 | $13.69 | 117.81% |
| 2022-03-11 | 11 | $82 | $16 | $29.454 | $13.69 | 115.15% |
| 2022-05-09 | 10 | $82 | $16 | $28.2 | $13.69 | 105.99% |
| 2022-06-06 | 10 | $82 | $16 | $28.4 | $13.69 | 107.45% |
| 2022-07-21 | 11 | $82 | $16 | $27 | $13.69 | 97.22% |
| 2022-07-27 | 10 | $82 | $16 | $27.2 | $13.69 | 98.69% |
| 2022-08-04 | 10 | $82 | $16 | $26.9 | $13.69 | 96.49% |
| 2022-09-17 | 10 | $82 | $16 | $26.7 | $13.69 | 95.03% |
| 2022-10-03 | 11 | $49 | $13.95 | $23.722 | $13.69 | 73.28% |
| 2022-11-01 | 11 | $49 | $13.95 | $23.54 | $13.69 | 71.95% |
| 2022-11-04 | 11 | $49 | $13.95 | $23.631 | $13.69 | 72.62% |
| 2023-01-18 | 11 | $49 | $13.95 | $23.45 | $13.69 | 71.29% |
| 2023-02-08 | 11 | $49 | $13.95 | $23.359 | $13.69 | 70.63% |
| 2023-02-27 | 12 | $49 | $13.95 | $22.912 | $13.69 | 67.36% |
| 2023-03-03 | 12 | $49 | $13.95 | $24.079 | $13.69 | 75.89% |
| 2023-03-07 | 12 | $49 | $14 | $25 | $13.69 | 82.62% |
The Trend in the Analyst Price Target
ICPT's average price target has moved down $23.13 over the prior 25 months.
Over the past 43 weeks, ICPT's average upside potential has been 56.08%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-09 | 10 | 82 | 16.00 | 28.200 | 18.01 | 56.58% |
| 2022-10-03 | 11 | 49 | 13.95 | 23.722 | 13.48 | 75.98% |
| 2023-01-22 | 11 | 49 | 13.95 | 23.359 | 16.12 | 44.91% |
| 2023-02-17 | 12 | 49 | 13.95 | 22.912 | 20.03 | 14.39% |
| 2023-03-03 | 12 | 49 | 14.00 | 25.000 | 20.68 | 20.89% |
ICPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.42 | 3 | 2 | 6 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
ICPT's average broker recommendation rating improved by 0.41 over the prior 16 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ICPT as an investment opportunity.
- In terms of how INTERCEPT PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2639.09% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, INTERCEPT PHARMACEUTICALS INC's number of analysts covering the stock is higher than 2330.04% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, INTERCEPT PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 2010.11% of them.
- In the context of stocks in the mid market cap category, INTERCEPT PHARMACEUTICALS INC's average analyst price target is higher than 1065.7% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to INTERCEPT PHARMACEUTICALS INC are FOLD, ENTA, and MDGL.
View All Top Stocks by Price Target
Is ICPT a Buy, Hold or Sell? See the POWR Ratings now!